AbbVie Inc. is 3.5x more valuable than Bristol-Myers Squibb Company by market capitalization ($399.47 B vs $114.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BMY | ABBV |
|---|---|---|
| Market cap | $114.08 B | $399.47 B |
| US-listed rank | #132 | #28 |
| Revenue (latest FY) | $48.19B | $61.16B |
| Net income (latest FY) | $7.05B | $4.23B |
| Net margin | 14.6% | 6.9% |
| P/E (trailing FY) | 16.2 | 94.5 |
| SEC filings | 1,000 | 1,008 |
AbbVie Inc. is 3.5x more valuable than Bristol-Myers Squibb Company by market capitalization ($399.47 B vs $114.08 B).
In their latest fiscal years, Bristol-Myers Squibb Company reported $48.19B in revenue while AbbVie Inc. reported $61.16B.
Full pages: Bristol-Myers Squibb Company and AbbVie Inc., or browse the full rankings.